vs
Side-by-side financial comparison of GENCOR INDUSTRIES INC (GENC) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
GENCOR INDUSTRIES INC is the larger business by last-quarter revenue ($23.6M vs $20.6M, roughly 1.1× Entrada Therapeutics, Inc.). GENCOR INDUSTRIES INC runs the higher net margin — 14.6% vs -84.4%, a 99.0% gap on every dollar of revenue. On growth, GENCOR INDUSTRIES INC posted the faster year-over-year revenue change (-25.0% vs -65.2%). GENCOR INDUSTRIES INC produced more free cash flow last quarter ($10.1M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -23.9%).
Gencor Industries Inc is a leading manufacturer of heavy construction and infrastructure equipment, specializing in asphalt production plants, thermal combustion systems, and supporting road-building machinery. It primarily serves North American and global construction markets, supplying products to both public sector infrastructure projects and private commercial construction operators.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
GENC vs TRDA — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $20.6M |
| Net Profit | $3.4M | $-17.3M |
| Gross Margin | 28.7% | — |
| Operating Margin | 13.2% | -106.0% |
| Net Margin | 14.6% | -84.4% |
| Revenue YoY | -25.0% | -65.2% |
| Net Profit YoY | -9.8% | -173.8% |
| EPS (diluted) | $0.23 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | — | ||
| Q3 25 | $18.8M | — | ||
| Q2 25 | $27.0M | — | ||
| Q1 25 | $38.2M | $20.6M | ||
| Q4 24 | $31.4M | $37.4M | ||
| Q3 24 | $20.9M | $19.6M | ||
| Q2 24 | $25.6M | $94.7M | ||
| Q1 24 | $40.7M | $59.1M |
| Q4 25 | $3.4M | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $6.1M | $-17.3M | ||
| Q4 24 | $3.8M | $1.1M | ||
| Q3 24 | $1.5M | $-14.0M | ||
| Q2 24 | $2.6M | $55.0M | ||
| Q1 24 | $6.2M | $23.5M |
| Q4 25 | 28.7% | — | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 29.7% | — | ||
| Q4 24 | 27.6% | — | ||
| Q3 24 | 25.6% | — | ||
| Q2 24 | 23.9% | — | ||
| Q1 24 | 30.3% | — |
| Q4 25 | 13.2% | — | ||
| Q3 25 | -1.2% | — | ||
| Q2 25 | 11.6% | — | ||
| Q1 25 | 17.0% | -106.0% | ||
| Q4 24 | 14.7% | -15.7% | ||
| Q3 24 | 5.9% | -110.7% | ||
| Q2 24 | 7.8% | 56.4% | ||
| Q1 24 | 17.4% | 35.7% |
| Q4 25 | 14.6% | — | ||
| Q3 25 | 10.2% | — | ||
| Q2 25 | 14.2% | — | ||
| Q1 25 | 16.0% | -84.4% | ||
| Q4 24 | 12.1% | 3.0% | ||
| Q3 24 | 6.9% | -71.7% | ||
| Q2 24 | 10.0% | 58.1% | ||
| Q1 24 | 15.3% | 39.7% |
| Q4 25 | $0.23 | — | ||
| Q3 25 | $0.13 | — | ||
| Q2 25 | $0.26 | — | ||
| Q1 25 | $0.42 | $-0.42 | ||
| Q4 24 | $0.26 | $-0.20 | ||
| Q3 24 | $0.10 | $-0.35 | ||
| Q2 24 | $0.17 | $1.55 | ||
| Q1 24 | $0.42 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.7M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $215.2M | $417.3M |
| Total Assets | $228.9M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $147.7M | — | ||
| Q3 25 | $136.3M | — | ||
| Q2 25 | $136.0M | — | ||
| Q1 25 | $143.7M | $67.8M | ||
| Q4 24 | $130.1M | $101.2M | ||
| Q3 24 | $115.4M | $78.0M | ||
| Q2 24 | $116.6M | $185.3M | ||
| Q1 24 | $117.1M | $68.4M |
| Q4 25 | — | — | ||
| Q3 25 | $0 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $215.2M | — | ||
| Q3 25 | $211.8M | — | ||
| Q2 25 | $209.9M | — | ||
| Q1 25 | $206.1M | $417.3M | ||
| Q4 24 | $200.0M | $428.7M | ||
| Q3 24 | $196.1M | $422.4M | ||
| Q2 24 | $194.7M | $429.9M | ||
| Q1 24 | $192.1M | $269.4M |
| Q4 25 | $228.9M | — | ||
| Q3 25 | $222.6M | — | ||
| Q2 25 | $220.2M | — | ||
| Q1 25 | $223.9M | $486.5M | ||
| Q4 24 | $218.2M | $526.3M | ||
| Q3 24 | $208.1M | $554.6M | ||
| Q2 24 | $201.8M | $582.0M | ||
| Q1 24 | $206.0M | $510.8M |
| Q4 25 | — | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.1M | $-38.5M |
| Free Cash FlowOCF − Capex | $10.1M | $-39.7M |
| FCF MarginFCF / Revenue | 43.0% | -192.9% |
| Capex IntensityCapex / Revenue | 4.1% | 5.6% |
| Cash ConversionOCF / Net Profit | 3.23× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-3.2M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.1M | — | ||
| Q3 25 | $-275.0K | — | ||
| Q2 25 | $-23.9M | — | ||
| Q1 25 | $12.4M | $-38.5M | ||
| Q4 24 | $14.8M | $-31.6M | ||
| Q3 24 | $-3.2M | $-24.3M | ||
| Q2 24 | $-1.0M | $39.8M | ||
| Q1 24 | $11.7M | $-25.5M |
| Q4 25 | $10.1M | — | ||
| Q3 25 | $-1.3M | — | ||
| Q2 25 | $-24.4M | — | ||
| Q1 25 | $12.3M | $-39.7M | ||
| Q4 24 | $14.5M | $-32.2M | ||
| Q3 24 | $-3.3M | $-24.9M | ||
| Q2 24 | $-1.4M | $38.8M | ||
| Q1 24 | $11.7M | $-26.4M |
| Q4 25 | 43.0% | — | ||
| Q3 25 | -6.8% | — | ||
| Q2 25 | -90.4% | — | ||
| Q1 25 | 32.2% | -192.9% | ||
| Q4 24 | 46.1% | -86.2% | ||
| Q3 24 | -15.8% | -127.3% | ||
| Q2 24 | -5.6% | 41.0% | ||
| Q1 24 | 28.7% | -44.6% |
| Q4 25 | 4.1% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 0.4% | 5.6% | ||
| Q4 24 | 1.0% | 1.7% | ||
| Q3 24 | 0.4% | 3.3% | ||
| Q2 24 | 1.5% | 1.1% | ||
| Q1 24 | 0.0% | 1.4% |
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | -27.94× | ||
| Q3 24 | -2.22× | — | ||
| Q2 24 | -0.41× | 0.72× | ||
| Q1 24 | 1.87× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
